335599-07-0

Basic information

• Product Name: 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI)
• Synonyms: 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI);Ethyl 3-oxa-bicyclo[3.1.0]hexane-6-carboxylate
• CAS NO: 335599-07-0
• Molecular Formula: C8H12O3
• Molecular Weight: 156.18
• Product Categories: CARBOXYLICESTER
• Mol File: 335599-07-0.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI)(335599-07-0)
• EPA Substance Registry System: 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI)(335599-07-0)

Safety Data

• Hazardous Substances Data: 335599-07-0(Hazardous Substances Data)

Usage

General Description

3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI) is a chemical compound with the molecular formula C9H14O3. It is an ester of a bicyclic carboxylic acid, and it has a six-membered oxygen-containing ring structure. 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI) is commonly used in organic synthesis and can be found in various chemical reactions and pharmaceutical applications. Its unique ring structure makes it an important building block for the synthesis of complex organic molecules. Additionally, it may have potential medicinal properties or be used as a precursor in the production of pharmaceutical drugs. Overall, 3-Oxabicyclo[3.1.0]hexane-6-carboxylicacid,ethylester(9CI) is a versatile chemical compound with a wide range of potential applications in the field of chemistry and pharmaceuticals.

Upstream product

• 1708-29-8 2,5-dihydrofuran 
• 623-73-4 diazoacetic acid ethyl ester 
• 5417-32-3 1,3-dioxa-5-cycloheptene 

Downstream Products

• 693248-53-2 3-Oxabicyclo<3.1.0>hexan-exo-6-carbonsaeure 
• 1398833-81-2 (3-oxa-bicyclo[3.1.0]hexan-6-yl)methanol 

Relevant articles and documents

ALKYNYL QUINAZOLINE COMPOUNDS

The present disclosure relates to compounds of Formula (I'): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the prevention or treatment of abnormal cell growth in mammals, especially humans.

Bcl-2 INHIBITORS

Disclosed herein is a compound of Formula (I) for inhibiting Bcl-2 and treating disease associated with undesirable bcl-2 activity (Bcl-2 related diseases), a method of using the compounds disclosed herein for treating dysregulated apoptotic diseases including cancers and treating autoimmune disease, and a pharmaceutical composition comprising the same.

Substituted acrylamido-penicillanic acid derivatives

Compounds of formula (I) and their derivatives: wherein X is hydrogen or a group NHR1, wherein R1 is hydrogen or an amino protecting group, and R is an optionally substituted spiro, fused or bridged bicyclic group optionally containing one or more heteroatoms selected from oxygen, nitrogen and sulphur, are new and useful in the treatment of bacterial infections in humans and animals.